Biotech IDEAYA Biosciences Enters Exclusive License with Hengrui Pharma for SHR-4849, a Novel Phase 1 DLL3 Topo-I-Payload ADC Targeting SCLC and NET Solid Tumors December 30, 2024
Biotech Precigen Announces $79.0 Million Private Placement Offering of Convertible Preferred Stock December 28, 2024
Biotech FireflySci Inc. Announces Price Increase in Response to Proposed Import Tariffs December 27, 2024
Biotech FDA Proposes Rule to Require Standardized Testing Methods for Detecting and Identifying Asbestos in Talc-Containing Cosmetic Products December 27, 2024
Biotech AusperBio Secures $73 Million in Series B Financing to Advance Functional Cure for Chronic Hepatitis B December 27, 2024
Biotech Global Multiomics Market Expected to Grow Rapidly, with 13.5% Annual Increase from 2024 to 2029 December 25, 2024
Biotech Bio-Thera Solutions Partners with Tabuk Pharmaceuticals to Commercialize BAT2206, a Stelara® (Ustekinumab) Biosimilar in Saudi Arabia December 25, 2024
Biotech Preliminary Results of Qilu Pharmaceutical’s Phase Ia Study on GPRC5D/CD3-Targeting Bispecific Antibody QLS32015 Unveiled at 2024 ASH Annual Meeting December 25, 2024
Biotech Neurocrine Biosciences, Inc. Selects PANTHERx®Rare Specialty Pharmacy for Distribution of Crenessity™ (crinecerfont) December 24, 2024